VRTX

Vertex Pharmaceuticals
D

VRTX

447.84
USD
-3.40
(-0.75%)
Market Open
Volume
2,655
EPS
0
Div Yield
-
P/E
-226
Market Cap
115,080,029,252
Related Instruments
    AMGN
    AMGN
    -12.22
    (-4.13%)
    286 USD
    BIIB
    BIIB
    -4.840
    (-2.94%)
    160.000 USD
    B
    BMRN
    -2.200
    (-3.35%)
    63.440 USD
    E
    EXEL
    -0.600
    (-1.71%)
    34.450 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    I
    IONS
    -2.970
    (-7.97%)
    34.290 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    More
News

Title: Vertex Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Vertex Pharmaceuticals is an American biopharmaceutical company in the business of researching, developing, manufacturing and marketing small molecule drugs for human patients with serious diseases. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, Massachusetts. Some of the diseases impacted by its therapies include cystic fibrosis; infectious diseases, including viral infections, such as influenza and bacterial infections; rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders. The company was one of the early pioneers of rational drug design rather than combinatorial chemistry.